Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
about
Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinomaHistory and current state of immunotherapy in glioma and brain metastasis.Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression.Anti-PD-L1 treatment enhances antitumor effect of everolimus in a mouse model of renal cell carcinoma.Melanoma central nervous system metastases: current approaches, challenges, and opportunities.Embracing rejection: Immunologic trends in brain metastasis.Immune Checkpoint Inhibitors for Brain Metastases.Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis.HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer.Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival.PD-L1 Expression and Combined Status of PD-L1/PD-1-Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma PatientsPredictive relevance of PD-L1 expression with pre-existing TILs in gastric cancer.Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer.Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy: A case report and review of the literature.Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms.Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival.Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma.Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases.PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes.Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors.Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor
P2860
Q26766240-52440C12-154C-44C7-B233-44DC07AB164AQ33656811-CC05B9CB-121E-4BA1-876F-BB09E35C0A4CQ33671093-805456AC-2F63-4001-A08E-FFBF58FE0DD0Q37584395-E1470B6E-2F57-4E89-9426-C686DF202B5EQ37701564-C9C61029-825A-47A1-8CBF-80154712245DQ38742200-51B23209-9473-44F3-B7FF-1187FC3731CAQ38807942-77FB3324-CA4A-4B18-AB6D-D1BFC02075E5Q38953017-DA181B74-D530-40BF-A1FC-E3B295A2CE2BQ39247421-2305C192-AEE4-4835-9EBE-E3414C5C9085Q40694392-885E7AEA-F5B3-46CA-A9B5-445ACDE010D1Q41431266-32A71B83-55AB-4862-B38D-5EC50F7A850CQ41472948-B4B57998-E644-4D4F-B3CF-6AF14728F34CQ41903951-31463AA7-3303-418F-9FCB-B2469161515AQ47137632-C0B39691-7BB3-4412-B4E1-B552B68B1A7BQ47162071-5F4ECAC9-7B05-4E7F-A700-8498D08DB49BQ47825909-6B2710A1-D433-4B02-B10D-43028786863CQ47917843-217B9541-2B04-4E6F-9E9B-B0A637C229C8Q48307824-7D79C9C6-0D31-449A-86FF-FF0EC55C5917Q51746346-99B987AB-3FD4-4392-B9A1-A5288040560CQ52733768-0EE43752-FFDD-473B-A78F-DD62A340B2D8Q54982136-F21F1B4F-75B6-4527-A56C-CB3ACFFB9070Q55029942-FC7D151E-51B5-4424-979D-39B2913EB9CCQ55263819-4A312D96-352B-4525-A98A-ADCF60CCB4C9Q57137831-AC50DA8B-C108-4A40-824F-6D28DD5CC63C
P2860
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Distribution and prognostic re ...... ints in human brain metastases
@ast
Distribution and prognostic re ...... ints in human brain metastases
@en
type
label
Distribution and prognostic re ...... ints in human brain metastases
@ast
Distribution and prognostic re ...... ints in human brain metastases
@en
prefLabel
Distribution and prognostic re ...... ints in human brain metastases
@ast
Distribution and prognostic re ...... ints in human brain metastases
@en
P2093
P2860
P50
P356
P1433
P1476
Distribution and prognostic re ...... ints in human brain metastases
@en
P2093
Alexander Scholz
Benjamin Bender
Benjamin Weide
Jenny Zinke
Joachim P Steinbach
Karl H Plate
Makoto Kiyose
Matthias Meinhardt
Pia S Zeiner
Simon Bernatz
P2860
P304
40836-40849
P356
10.18632/ONCOTARGET.5696
P407
P50
P577
2015-10-16T00:00:00Z